BackSILO Pharma Overview

SILO Pharma Long Term Debt

Latest long-term debt for SILO: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

SILO Pharma Long Term Debt History

Loading

SILO Pharma vs. peers: Long Term Debt Comparison

Loading

SILO Pharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

SILO Pharma (SILO) FAQ

SILO Pharma (SILO) currently reports a long-term debt of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore SILO Pharma's long-term debt history and peer comparisons.

SILO Pharma's long-term debt changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SILO Pharma reported $0 in long-term debt as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SILO Pharma, and consider following SILO for alerts when major investors trade the stock.

SILO Pharma is classified in the Finance sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing SILO with unrelated industries.